0.56; 95%CI [0.33-0.95]). Subgroup analysis including only OSA showed a similar result after adjustement (p=0.017; HR: 0.40;). In multivariate cox analysis including all the polygraphic variables, only CSR and minimal oxyhemoglobin saturation predicted adverse outcomes in all CHF patients untreated for SDB but AHI.
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Metaboreflex attenuation as a potential cause of improvement in the ventilatory response after cardiac resynchronization therapy Jérémie Jaussaud [Orateur] , Laurie Aimable, Pierre Bordachar, Raymond Roudaut, Hervé Douard CHU Bordeaux, Bordeaux, France Background: Patients suffering from heart failure (HF) have constant exaggerated hyperventilation (high VE/VCO2) leading to breathlessness and reduced exercise capacity. Metaboreflex over activation has been proposed to partly explain this high ventilatory response during exercise.
Objective:
We aim to investigate the modification of the metaboreflex activation as a determinant in the improvement of the ventilatory response 6 months after CRT.
Methods and results: 10 HF patients (mean left ventricular ejection (LVEF) 27±4%, peak VO2 14±4 ml/kg/min, NYHA class 2,6±0,5; QRS duration >120 ms) schedulded for CRT implantation were prospectively studied. At baseline and after 6 month follow up two maximal cardiopulmonary exercise tests with and without regional circulatory occlusion (RCO) were performed with continuous VE, respiratory ratio (RR), VCO2 and VO2 measurements. RCO was achieved by inflation of bilateral upper thigh tourniquets 30 mmHg above peak systolic blood pressure during 3 minutes after peak exercise as previously described. Metaboreflex contribution to the ventilatory response was assessed as the difference in ventilatory data at the third minute during recovery between the two tests (RCO -no RCO='). At baseline, patients had enhanced VE/VCO2 slope (40±9) and an evident metaboreflex contribution to the high ventilatory response ('VE: 3±4 L/min; p=0.01, 'RR: 4.5±4/min; p=0.01). 6 months after CRT implantation, NYHA class, LVEF, peak VO2 and VE/VCO2 were significantly improved (1,5±0,5; p<0.001, 42±7%; p<0.001, 16±4 ml/kg/min; p=0.005; 33±9; p=0.001). Metaboreflex contribution to ventilation was reduced compared with baseline ('VE: -1±5; p=0.08, 'RR: -1±3; p=0.01).
Conclusion: 6 months after CRT metaboreflex contribution to ventilation is reduced and appears as an explanation in the ventilatory response improvement in HF population.
